^
    Apply
    Evaluate Safety and the Oncolitic Adenovirus VCN-01 Activity in Patients With Refractory Retinoblastoma (RTB) (NCT03284268)
    Phase N/A
    Fundació Sant Joan de Déu
    Active, not recruiting
    Last update posted :
    04/22/2024
    Initiation :
    09/06/2017
    Primary completion :
    06/15/2024
    Completion :
    07/01/2024
    RB1
    |
    RB1 mutation
    |
    VCN-01
    Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma (NCT03799744)
    Phase 1
    Institut Català d'Oncologia
    Active, not recruiting
    Last update posted :
    03/28/2022
    Initiation :
    03/20/2019
    Primary completion :
    01/31/2023
    Completion :
    01/31/2023
    IL6 • IL10
    |
    Imfinzi (durvalumab) • VCN-01